Back to Search
GINA M EVERSON MD
MD
Family Medicine Physician
NPI: 1124019799IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
46760(WI)
Education
MEDICAL COLLEGE OF WISCONSIN
Class of 2001
Research & Publications (20)
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
PMID 18848939·Gastroenterology·2009
8-other
Hepatitis C virus: a critical appraisal of approaches to therapy.
PMID 19114127·Clin Gastroenterol Hepatol·2009
6-review
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
PMID 19291787·Hepatology·2009
2-rct
Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-C trial.
PMID 19053983·Aliment Pharmacol Ther·2009
2-rct
Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.
PMID 19403902·N Engl J Med·2009
3-trial
High relapse rate seen at week 72 for patients treated with R1626 combination therapy.
PMID 18821613·Hepatology·2008
8-other
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.
PMID 19052125·N Engl J Med·2008
4-observational
Is early steroid withdrawal after liver transplantation feasible with tacrolimus monotherapy?
PMID 18301405·Nat Clin Pract Gastroenterol Hepatol·2008
2-rct
The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial.
PMID 18266997·Aliment Pharmacol Ther·2008
8-other
Central alpha-2 adrenergic eye drops: case series of 3 pediatric systemic poisonings.
PMID 18347496·Pediatr Emerg Care·2008
5-case
Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C.
PMID 18816437·Hepatology·2008
8-other
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.
PMID 18157835·Hepatology·2008
2-rct
Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis.
PMID 18208570·Aliment Pharmacol Ther·2008
2-rct
Reproduction, larval growth, and reproductive development in African clawed frogs (Xenopus laevis) exposed to atrazine.
PMID 18001816·Chemosphere·2008
7-preclinical
R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin.
PMID 18570306·Hepatology·2008
3-trial
Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
PMID 17927714·Liver Int·2008
4-observational
Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C.
PMID 18081733·Aliment Pharmacol Ther·2008
4-observational
Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C.
PMID 18237873·Clin Gastroenterol Hepatol·2008
8-other
Advances in management of polycystic liver disease.
PMID 19072404·Expert Rev Gastroenterol Hepatol·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 420 E DIVISION ST
FOND DU LAC, WI 54935 - Phone
- (920) 926-8200
Quick Facts
- NPI
- 1124019799
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 25
- Publications
- 20
Are you this provider?
Claim Your Profile